Please Wait...

Martin Collyer

Translation skills

Main profile

Martin Collyer
Martin Collyer
Chief Operating Officer, Patient Recruitment

Martin is a senior healthcare and life sciences executive with more than 20 years of experience and a strong operations and finance background. He has achieved an exemplary track record in strategic planning, ROI maximization, team development and multi-site global operations management. He is an astute operations leader versed in the alignment of strategic solutions and business operations and development of cross-enterprise alliances. Martin enables organizations to expedite the enrollment of patients into their clinical trials utilizing therapeutically aligned global patient engagement platforms and digital methodologies. Martin is a qualified Chartered Certified Accountant with a degree in strategic financial planning and management. Prior to joining Bioclinica in 2016 he was chief operating officer of MediciGroup, since acquired by Bioclinica, and he spent four years with Hitachi solving big data challenges.


As an industry, we assign considerable resources and money to the recruitment and enrollment of patients, but tend to focus less effort on finding patients that drop out of the trial. We know that lost patients compromise the integrity of our data, and therefore regulatory submissions. However, replacing lost patients with new patients costs money and takes time.


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil…
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace…
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c…
bioclinica (Yesterday)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '…
bioclinica (6 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen